239 related articles for article (PubMed ID: 25453264)
1. Stress urinary incontinence animal models as a tool to study cell-based regenerative therapies targeting the urethral sphincter.
Herrera-Imbroda B; Lara MF; Izeta A; Sievert KD; Hart ML
Adv Drug Deliv Rev; 2015 Mar; 82-83():106-16. PubMed ID: 25453264
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells for sphincter regeneration.
Klein G; Hart ML; Brinchmann JE; Rolauffs B; Stenzl A; Sievert KD; Aicher WK
Adv Drug Deliv Rev; 2015 Mar; 82-83():123-36. PubMed ID: 25451135
[TBL] [Abstract][Full Text] [Related]
3. Cell Therapy for Stress Urinary Incontinence.
Hart ML; Izeta A; Herrera-Imbroda B; Amend B; Brinchmann JE
Tissue Eng Part B Rev; 2015 Aug; 21(4):365-76. PubMed ID: 25789845
[TBL] [Abstract][Full Text] [Related]
4. Stress urinary incontinence and regenerative medicine: is injecting functional cells into the urethra feasible based on current knowledge and future prospects?
Aufderklamm S; Aicher WK; Amend B; Stenzl A
Curr Opin Urol; 2019 Jul; 29(4):394-399. PubMed ID: 31033573
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence.
Corcos J; Loutochin O; Campeau L; Eliopoulos N; Bouchentouf M; Blok B; Galipeau J
Neurourol Urodyn; 2011 Mar; 30(3):447-55. PubMed ID: 21412824
[TBL] [Abstract][Full Text] [Related]
6. Stem Cell Therapy for Male Urinary Incontinence.
Giberti C; Gallo F; Schenone M; Cortese P; Ninotta G
Urol Int; 2013; 90(3):249-52. PubMed ID: 23221307
[TBL] [Abstract][Full Text] [Related]
7. Regenerative Medicine Therapies for Stress Urinary Incontinence.
Williams JK; Dean A; Badlani G; Andersson KE
J Urol; 2016 Dec; 196(6):1619-1626. PubMed ID: 27544623
[TBL] [Abstract][Full Text] [Related]
8. New concepts in regenerative medicine approaches to the treatment of female stress urinary incontinence.
Bennington J; Williams JK; Andersson KE
Curr Opin Urol; 2019 Jul; 29(4):380-384. PubMed ID: 30855380
[TBL] [Abstract][Full Text] [Related]
9. Applicability of regenerative medicine and tissue engineering for the treatment of stress urinary incontinence in female patients.
Zambon JP; Williams KJ; Bennington J; Badlani GH
Neurourol Urodyn; 2019 Aug; 38 Suppl 4():S76-S83. PubMed ID: 31099087
[TBL] [Abstract][Full Text] [Related]
10. Stem cell therapy for stress urinary incontinence.
Nikolavsky D; Chancellor MB
Neurourol Urodyn; 2010; 29 Suppl 1():S36-41. PubMed ID: 20419800
[TBL] [Abstract][Full Text] [Related]
11. Small intestinal submucosa urethral wrap at the time of artificial urinary sphincter placement as a salvage treatment option for patients with persistent/recurrent incontinence following multiple prior sphincter failures and erosions.
Trost L; Elliott D
Urology; 2012 Apr; 79(4):933-8. PubMed ID: 22119252
[TBL] [Abstract][Full Text] [Related]
12. Development of stem cell therapy for stress urinary incontinence.
Ho CP; Bhatia NN
Curr Opin Obstet Gynecol; 2012 Oct; 24(5):311-7. PubMed ID: 22954763
[TBL] [Abstract][Full Text] [Related]
13. Combined external urethral bulking and artificial urinary sphincter for urethral atrophy and stress urinary incontinence.
Rahman NU; Minor TX; Deng D; Lue TF
BJU Int; 2005 Apr; 95(6):824-6. PubMed ID: 15794791
[TBL] [Abstract][Full Text] [Related]
14. Regeneration of degenerated urinary sphincter muscles: improved stem cell-based therapies and novel imaging technologies.
Amend B; Vaegler M; Fuchs K; Mannheim JG; Will S; Kramer U; Hart ML; Feitz W; Chapple C; Stenzl A; Aicher WK
Cell Transplant; 2015; 24(11):2171-83. PubMed ID: 25608017
[TBL] [Abstract][Full Text] [Related]
15. Slings for urinary incontinence and the application of cell-based therapy.
Hakim L; De Ridder D; Van der Aa F
Adv Drug Deliv Rev; 2015 Mar; 82-83():22-30. PubMed ID: 25463774
[TBL] [Abstract][Full Text] [Related]
16. The urethral closure function in continent and stress urinary incontinent women assessed by urethral pressure reflectometry.
Saaby ML
Dan Med J; 2014 Feb; 61(2):B4795. PubMed ID: 24495894
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Analysis of Human Mesenchymal Stem Cell Therapy in Incontinent Rat Injured Urethra.
Sadeghi Z; Kenyon JD; Richardson B; Khalifa AO; Cartwright M; Conroy B; Caplan A; Cameron MJ; Hijaz A
Tissue Eng Part A; 2020 Jul; 26(13-14):792-810. PubMed ID: 32614683
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of urinary incontinence in murine models.
Koike Y; Furuta A; Suzuki Y; Honda M; Naruoka T; Asano K; Egawa S; Yoshimura N
Int J Urol; 2013 Jan; 20(1):64-71. PubMed ID: 23126617
[TBL] [Abstract][Full Text] [Related]
19. Experimental study of therapy of bone marrow mesenchymal stem cells or muscle-like cells/calcium alginate composite gel for the treatment of stress urinary incontinence.
Du XW; Wu HL; Zhu YF; Hu JB; Jin F; Lv RP; Sun S; Wang HY; Xu JW
Neurourol Urodyn; 2013 Mar; 32(3):281-6. PubMed ID: 22847293
[TBL] [Abstract][Full Text] [Related]
20. Cell Therapy by Mesenchymal Stromal Cells Versus Myoblasts in a Pig Model of Urinary Incontinence.
Knoll J; Amend B; Harland N; Isser S; Bézière N; Kraushaar U; Stenzl A; Aicher WK
Tissue Eng Part A; 2024 Jan; 30(1-2):14-30. PubMed ID: 37933911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
